Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study-Reference-Cited by-同舟云学术

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Published:2016-02 Issue:2 Volume:17 Page:200-211
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Chanan-Khan Asher,Cramer Paula,Demirkan Fatih,Fraser Graeme,Silva Rodrigo Santucci,Grosicki Sebastian,Pristupa Aleksander,Janssens Ann,Mayer Jiri,Bartlett Nancy L,Dilhuydy Marie-Sarah,Pylypenko Halyna,Loscertales Javier,Avigdor Abraham,Rule Simon,Villa Diego,Samoilova Olga,Panagiotidis Panagiots,Goy Andre,Mato Anthony,Pavlovsky Miguel A,Karlsson Claes,Mahler Michelle,Salman Mariya,Sun Steven,Phelps Charles,Balasubramanian Sriram,Howes Angela,Hallek Michael

Publisher

Elsevier BV

Subject

Oncology

Reference21 articles.

1. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions;Goede;N Engl J Med,2014

2. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial;Hallek;Lancet,2010

3. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia;Tam;Blood,2008

4. Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2011

5. Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group;Fischer;J Clin Oncol,2011

Cited by 379 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic lymphocytic leukaemia;The Lancet;2024-08

2. Ibrutinib-induced spinal haematoma in a patient with marginal zone lymphoma;BMJ Case Reports;2024-08

3. Bruton tyrosine kinase inhibitor-related atrial fibrillation and its implications in the treatment of B-cell lymphoma;Frontiers in Cardiovascular Medicine;2024-07-26

4. Frequent response monitoring in chronic lymphocytic leukemia clinical trials: what is the value?;Blood Neoplasia;2024-06

5. Engineering Dimeric EGFR-directed IgA Antibodies Reveals a Central Role of CD147 during Neutrophil-mediated Tumor Cell Killing of Head and Neck Squamous Cancer Cells;The Journal of Immunology;2024-05-24